在慢性疼痛和阿片类药物使用中改变奖励驱动注意力的神经相关性
Su Hyoun Park1,2,3, Anne K Baker4,5,6, Katherine T Martucci4,5
1Department of Anesthesiology, Human Affect and Pain Neuroscience Laboratory, Duke University School of Medicine, Durham, NC, USA. suhyounpark@gmail.com.
Scientific reports
|April 25, 2025
概括
慢性疼痛,像纤维肌痛一样,改变了脑在下额前环 (IFG) 和侧皮层 (LOC) 中的奖励处理. 使用阿片类药物可能会减轻这些影响,疼痛持续时间会影响注意力电路.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 医疗成像医学成像
背景情况:
- 在慢性疼痛条件下,对奖励的注意处理可能会发生变化.
- 神经回路和阿片类药物使用对这些慢性疼痛变化的影响仍然不清楚.
研究的目的:
- 研究纤维肌痛患者在奖励任务期间注意力处理的神经表现.
- 检查阿片类药物使用和疼痛持续时间对这些神经回路的影响.
主要方法:
- 从纤维肌痛患者 (服用或不服用阿片类药物) 和无疼痛对照组收集功能磁共振成像 (fMRI) 数据.
- 在奖励任务期间,分析了下额回环 (IFG) 和侧皮质 (LOC) 中的大脑活动和功能连接.
主要成果:
- 在纤维肌痛患者的奖励预期期间观察到IFG反应的减少 (未经纠正,p = 0.05).
- 与对照组相比,患者的LOC-IFG功能连接性显著降低 (p-FDR修正=0.026),主要是在非阿片类药物使用者中.
- 在非阿片类药物患者中,疼痛持续时间缓和了LOC-IFG连接和任务执行之间的关系 (p = 0.031).
结论:
- 在纤维肌痛中,奖励的注意处理在LOC-IFG大脑电路中发生变化.
- 使用阿片类药物可能会减轻这些变化.
- 疼痛持续时间较长可能对注意力处理行为和神经回路产生累积影响.
相关概念视频
Analgesia and Pain Management
397
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
397
Attention-Deficit/Hyperactivity Disorder
23
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
23
Opioid Receptors: Overview
324
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
324
Drug Abuse and Addiction: Pharmacological Phenomena
410
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
410
Opioid Analgesics: Synthetic and Semisynthetic Opioids
171
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
171


